Clinical trial · Interventional
Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
Artificial Intelligence Pulmonary Watershed Terrain Navigation System for Lung Nodule Localization and Lung Function Preservation
NCT06404164CI-TRIAL-00076900recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A method of ICG counterstaining localization under target artery occlusion without cutting，It's a new method of localization of small pulmonary nodules.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Disease Free Survival | — | UNRESOLVED | — |
| NSCLC, Stage I | Lung Non-Small Cell Carcinoma | CURATED_BROADER | 0.78 |
| Pulmonary Function Assessment | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Wedge resection under watershed analysis method | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Watershed analysis
- interventionNames
- Procedure: Wedge resection under watershed analysis method
Primary outcomes (1)
- measure
- Lung fuction
- timeFrame
- 1month 3month 1year
- description
- testing FEV1 and FVC with MIR Spirolab
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. \<1cm CTR≤0.75; \<1.5cm CTR≤0.5; \<2cm CTR≤0.25 Lung nodules 2. The tumor center is located in the peripheral 2/3 area of the lung field 3. Preoperative analysis and planning of watershed by 3D reconstruction 4. Clinically assessed as cT1aN0M0 stage IA1/cT1bN0M0 stage IA2 (eighth edition), clinically resectable Exclusion Criteria: 1. No surgical video, no postoperative gross specimen and related distance measurement records 2. The incision edge does not exceed the target nodule diameter from the nodule edge 3. The resection range exceeds 50% of the preoperative planning 4. Postoperative pathological staging non-pT1aN0M0 IA1 stage/pT1bN0M0 IA2 stage (eighth edition) 5. Any situation where the investigator feels the need for extended resection 6. Patients with chronic diseases (such as COPD, pulmonary fibrosis, silicosis) that can cause loss of lung function in patients at risk of progression or potential progression
References
Publications (0)
Data not yet available
No reference posted for this study.